Year-end report January-December 2024 CombiGene AB (Publ)
February 14, 2025
October – December 2024 Net sales: 0 (596) TSEK. Other operating income: 1,962 (875) TSEK. Result
October – December 2024 Net sales: 0 (596) TSEK. Other operating income: 1,962 (875) TSEK. Result
CombiGene AB (publ) (“CombiGene”, the “Company”) today announces that the Board of CombiGene has decided to
CombiGene AB (publ) (“CombiGene”, the “Company”) today announces that Strategic Partners A/S have sold 2,327,058 shares
CombiGene AB (publ) (“CombiGene”, the “Company”) would like to clarify this morning’s memo by stating that
The Board of CombiGene AB (publ) (“CombiGene”, the “Company”) today announces that a first step has
The nominating committee has been constituted in accordance with the resolution adopted by the annual general
CombiGene AB (publ) (the “Company”) held an extraordinary general meeting (“EGM”) on 10 December 2024 via
CombiGene AB (publ) (“CombiGene”, the “Company”) hereby reminds its shareholders to attend the Extraordinary General Meeting
The shareholders of CombiGene AB (publ) (“CombiGene” or the “Company”) have previously been given notice to
July – September 2024• Net sales: TSEK 0 (992).• Other operating revenues: TSEK 793 (173).• Profit